10x Genomics to Collaborate with QIAGEN, N.V. for Co-Marketing and Co-Development of Sequencing and Single Cell Analysis Workflows and Informatics Solutions

10x Genomics, Inc. today announced the establishment of a co-marketing and co-development collaboration with QIAGEN N.V. for the co-promotion and co-development of integrated workflow solutions for nucleic acid sequencing and single cell analysis.
According to Serge Saxonov, 10x’s Chief Executive Officer:

We welcome the opportunity to partner with QIAGEN, with their comprehensive offerings for genomic analysis, ranging from sample preparation technologies to bioinformatics solutions for the interpretation and analysis of genomic data. Access to long-range sequence information is becoming the standard for obtaining the most comprehensive understanding of disease, and we expect this collaboration to allow our respective customers to gain valuable insights that have previously not been possible.

Click here to view the full press release.